Loss of a demethylase activity has been previously proposed as the cause of promoter hypermethylation events commonly observed in transformed cell lines and cancer cells, and inhibition of Tet methylcytosine dioxygenase activity is directly linked with increased 5mC, while over-expression of Tet1 leads to global demethylation [11,30]. The gene discussed is MBD2; the disease is cancer.